Home - Gastroenterology Advisor
GIP/GLP-1 RA Beneficial for Patients With Opioid, Alcohol Use Disorder. Cognitive Therapy, Modafinil, Combo All Beneficial for Multiple Sclerosis Fatigue. 2010 to 2023 Saw Increase in GLP-1 RA, SGLT2 Inhibitor Use in Type 1 Diabetes. Many More Lives Could Have Been Saved With Convalescent COVID-19 Plasma.
Clinician Insights on How to Manage Semaglutide-Induced …
Sep 8, 2023 · Patients who receive treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, such as semaglutide, may experience delayed gastric emptying due to the drug’s mechanism of action (MOA). 1 Symptoms may include nausea, vomiting, heartburn, pain, or bloating. 2 However, the symptoms of delayed gastric emptying resulting from GLP-1 receptor agonists may be similar to symptoms of ...
What We Know About Semaglutide Adverse Events and …
Sep 1, 2023 · There were no reports of gastroparesis in the study. 1. While semaglutide and other GLP-1 agonists cause adverse events, such as nausea, vomiting, diarrhea, and a range of other GI symptoms, these effects of delayed gastric emptying are reported to be reduced after 20 weeks of use. 2. [T]here are some cases where gastroparesis may resolve if ...
FDA Approves Vyloy for Advanced Gastric or Gastroesophageal …
7 hours ago · HealthDay News — The U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of adults with locally advanced unresectable or metastatic human epidermal growth factor receptor 2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors are claudin ...
New Oral Tablet Prep for Colonoscopy: The Important Details
Feb 8, 2021 · Importance of Adequate Bowel Prep. From the perspective of the gastroenterologist, adequate bowel prep is crucial in screening colonoscopy, for which it is used to detect cancerous and precancerous lesions, and in diagnostic colonoscopy, such as that performed because of bleeding or diarrhea. Up to 25% of patients undergoing colonoscopy may ...
GLP-1 RA Medications in Established GERD Lowers Mortality Risk
Oct 29, 2024 · Patients with a history of gastroesophageal reflux disease (GERD) who initiate treatment with glucagonlike peptide-1 receptor agonist (GLP-1RA) medications are at lower risk for mortality and proton pump inhibitor (PPI) initiation, according to study results presented at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting and Postgraduate Course, held in Philadelphia ...
Bile Reflux: Clinical Considerations - Gastroenterology Advisor
Nov 5, 2021 · Bile reflux occurs when the bile secreted into the duodenum moves retrograde into the stomach and potentially into the esophagus. 2 Biliary reflux has also been called duodeno-gastroesophageal reflux (DGER), biliary gastritis, or alkaline reflux gastritis. 1,3 In certain patients with bile reflux, it has been postulated that a weak or widely patent pylorus could predispose patients to this ...
Gastroparesis Awareness Month: Updated Guidelines to Treat …
Aug 19, 2022 · The American College of Gastroenterology (ACG) released updated clinical guidelines on managing gastroparesis (GP). The new recommendations were published in The American Journal of Gastroenterology.. GP is characterized by delayed gastric emptying (GE) of solid food in the absence of mechanical obstruction.
Gastric Intestinal Metaplasia: 2020 AGA Guidelines
Mar 12, 2020 · 5. Gupta S et al. AGA clinical practice guidelines on management of gastric intestinal metaplasia. Gastroenterology. 2020;158 (3):693-702. 6. Gawron AJ, Shah SC, Altayar O, et al. AGA technical review on gastric intestinal metaplasia—natural history and clinical outcomes. Gastroenterology. 2020;158 (3):705-731. 7.
2021 American College of Gastroenterology Guidelines: Prevention ...
Aug 25, 2021 · The American College of Gastroenterology (ACG) released updated clinical guidelines on the prevention, diagnosis, and treatment of Clostridioides difficile infections (CDI), which was recently published in The American Journal of Gastroenterology.These guidelines represent the official practice recommendations of the ACG and indicate the preferred approach to the management of adults with CDI.